The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Rise of the phoenix: Mucormycosis in COVID-19 times
Open accessAbstract
Purpose: Rhino-orbital mucormycosis in times of ongoing COVID-19 pandemic. Aims: The aim of the study was to document cases of rhino-orbital mucormycosis seen at our Regional Institute of Ophthalmology during COVID-19 (coronavirus disease 2019) times. Methods: The study is a retrospective, institutional cohort, interventional study. It was carried out at our Regional Institute of Ophthalmology from September 2020 to mid-March 2021. All patients of biopsy-proven mucormycosis were enrolled in the study. The patients were subjected to complete history taking, ophthalmological examination, and imaging studies. The patients were treated via a multidisciplinary approach with intravenous liposomal amphotericin B and debridement of local necrotic tissue. Exenteration was done when indicated. A minimum 75-day follow-up period was accorded to all study patients. Statistical analysis was done using Chi-square test. A P value ≤0.05 was taken as significant. Results: Thirty-one patients were seen, with a mean age of 56.3 years. The major risk factors included uncontrolled diabetes (96.7%) and COVID-19 positivity (61.2%), with concomitant steroid use in 61.2% patients. The most common presentation was diminution of vision (<6/60 in 80.64% patients) and ophthalmoplegia (77.4%). The most common imaging findings were orbital cellulitis (61.29%) and pansinusitis (77.4%). Intravenous liposomal amphotericin B was given to all patients for an average 18.93 days. Exenteration was required in (n = 4) 12.9% of cases. Twenty-eight patients recovered and were alive on follow-up. Mortality was seen in three patients. The presence of cerebral involvement and a HbA1c value of ≥8 were found to be significant in the prediction of survival of patients with mucormycosis. Conclusion: We present the largest institutional cohort of rhino-orbital mucormycosis patients during the ongoing COVID-19 pandemic era from our unique perspective.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Invasive fungal infections after natural disasters
Benedict, K., & Park, B. J. (2014) · Emerging Infectious Diseases · doi:10.3201/eid2003.131230 · Cited by 199
Cited by
COVID-19-associated fungal infections
Hoenigl, M., Seidel, D., Sprute, R., Cunha, C., Oliverio, M., Goldman, G. H., Ibrahim, A. S., & Carvalho, A. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01172-2 · Cited by 482
Sen, M., Honavar, S. G., Bansal, R., Sengupta, S., Rao, R., Kim, U., Sharma, M., Sachdev, M., Grover, A. K., Surve, A., et al. (2021) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_1565_21 · Cited by 418
Self-citationHonavar, S. G. (2021) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_1165_21 · Cited by 309
Metadata
- Authors
- Ravani, S. A., Agrawal, G. A., Leuva, P. A., Modi, P. H., & Amin, K. D.
- Venue
- Indian Journal of Ophthalmology
- Published
- 2021-05-21
- Volume
- 69
- Issue
- 6
- Pages
- 1563-1568
- ISSN
- 0301-4738 (ISSN-L)
- 1998-3689
- OpenAlex
- W3162501078
- Cited by
- 197
- References
- 1
- FWCI
- 13.70
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Rise of the phoenix: Mucormycosis in COVID-19 times. https://app.cochat.ai/papers/10.4103/ijo.ijo_310_21
- The paper
- Ravani, S. A., Agrawal, G. A., Leuva, P. A., Modi, P. H., & Amin, K. D. (2021). Rise of the phoenix: Mucormycosis in COVID-19 times. Indian Journal of Ophthalmology. https://doi.org/10.4103/ijo.ijo_310_21
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.